Skip to main content
. 2022 Mar 31;15(1):34–41. doi: 10.4103/jhrs.jhrs_147_21

Table 1.

Comparison of characteristics of cases and controls

Characteristic Cases (n=35) Controls (n=35) Significance of difference
Mean age±SD (years) 23.94±4.45 23.83±4.64 t=0.105; P=0.917
Mean BMI±SD (kg/m2) 27.61±5.74 25.37±4.35 t=1.842; P=0.070
BMI category (kg/m2), n (%)
 Normal weight (18.5-22.9) 9 (25.7) 10 (28.6) χ2=0.545; P=0.762
 Overweight (23-24.9) 10 (28.6) 12 (34.3)
 Obese (>25.0) 16 (45.7) 13 (37.1)
Mean fasting glucose±SD (mg/dl) 94.06±10.27 81.77±8.82 t=5.369; P<0.001
Mean fasting insulin±SD (µmol/L) 23.35±33.35 11.09±12.05 t=2.034; P=0.046
Hyperinsulinaemia, n (%) 4 (11.4) 2 (5.7) χ2=0.729; P=0.393
Mean HOMA-IR±SD 5.61±8.56 2.29±2.63 t=2.191; P=0.032
Insulin resistance, n (%) 23 (65.7) 10 (28.6) χ2=9.689; P=0.002
Mean HCy±SD (µmol/L) 17.93±9.86 10.32±5.95 t=3.911; P<0.001
Hyperhomocysteinaemia, n (%) 22 (62.9) 7 (20.0) χ2=13.25; P<0.001

SD=Standard deviation, BMI=Body mass index, HOMA-IR=Homoeostatic assessment of insulin resistance